Federally-Listed PSOs

Below is a list of PSOs that are currently listed by AHRQ. A health care provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO.

Use the categories on the left to filter the list of PSOs or search a PSO name.

Note: AHRQ updates the PSO information contained within the directories weekly, as needed; changes are made when there are newly listed PSOs and/or when existing information requires revision. Changes that would otherwise be effective on a weekend day or holiday will be effective on the next business day. Information contained in the directories is based on attestations that the PSOs provide. To update PSO contact information, please use the Change of Listing Information form; to update profile information, please go to the PSO PPC Web site.

There are 87 total PSOs listed by AHRQ.

PLEASE NOTE: To search for a PSO by State, use the 2 letter state abbreviation. Example: Kansas = KS

Alliance for Patient Medication Safety - P0020
Component of Parent Org(s):
  • NASPA
Effective Date and Time of Initial Listing: December 10, 2008 12:01 AM ET
PSO Mailing Address: 2530 Professional Road, Suite 202, Richmond, VA 23235
PSO Phone Number: (804) 422-6311
Point of Contact: Taramarie (Tara) Modisett
Point of Contact Phone: (804) 422-6311, ext. 107
Point of Contact Email: tara@naspa.us (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 12/10/2020 through 12/09/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
American Data Network PSO - P0051
Component of Parent Org(s):
  • American Data Network
Effective Date and Time of Initial Listing: February 25, 2009 12:01 AM ET
PSO Mailing Address: 10809 Executive Center Drive, Searcy Building, Suite 300, Little Rock, AR 72211
PSO Phone Number: (501) 225-5533, ext. 103
Point of Contact: Stephanie Iorio
Point of Contact Phone: (501) 537-7942
Point of Contact Email: siorio@americandatanetwork.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 02/25/2019 through 02/24/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Ascension Healthcare Patient Safety Organization - P0111
Component of Parent Org(s):
  • Ascension
Effective Date and Time of Initial Listing: May 11, 2011 12:01 AM ET
PSO Mailing Address: 4600 Edmundson Road, St. Louis, MO 63134
PSO Phone Number: 314-733-8164
Point of Contact: Ruth Eaker
Point of Contact Phone: 314-733-8164
Point of Contact Email: Ruth.Eaker@ascension.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 05/11/2021 through 05/10/2023
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: Yes
CHPSO - P0002
Component of Parent Org(s):
  • California Association of Hospitals and Health Systems (CAHHS)
  • Hospital Quality Institute (HQI)
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
PSO Mailing Address: 1215 K Street, Suite 800, Sacramento, CA 95814
PSO Phone Number: (916) 552-2600
Point of Contact: Barbara Abeling PhD, MS, RN
Point of Contact Phone: 916-552-7614
Point of Contact Email: babeling@chpso.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2020 through 11/04/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
CHS PSO, LLC - P0122
Component of Parent Org(s):
  • CHS/Community Health Systems, Inc.
Effective Date and Time of Initial Listing: January 11, 2012 12:01 AM ET
PSO Mailing Address: 4000 Meridian Boulevard, Franklin, TN 37067
PSO Phone Number: (615) 465-7000
Point of Contact: Terrie Van Buren RN, BSN, MBA, CPPS
Point of Contact Phone: 615-465-7518
Point of Contact Email: terrie_vanburen@chs.net (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 01/11/2020 through 01/10/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Center for Patient Safety - P0011
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
PSO Mailing Address: 4215 Philips Farm Rd, Ste 101-A, Columbia, MO 65201
PSO Phone Number: 573-636-1014
Point of Contact: Alexandra Christgen
Point of Contact Phone: (573) 636-1014
Point of Contact Email: achristgen@centerforpatientsafety.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2018 through 11/04/2020
Disclosures & Finding: None
Clarity PSO - P0015
Component of Parent Org(s):
  • Clarity Group, Inc.
Effective Date and Time of Initial Listing: November 19, 2008 12:01 AM ET
PSO Mailing Address: 8725 W Higgins Road, Suite 810, Chicago, IL 60631
PSO Phone Number: (773) 867-8066
Point of Contact: Thomas F. Piotrowski
Point of Contact Phone: (773) 867-8066
Point of Contact Email: tpiotrowski@claritypso.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/19/2018 through 11/18/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
HCA Patient Safety Organization, LLC - P0157
Component of Parent Org(s):
  • HCA Holdings, Inc. (direct parent: EP Holdco, LLC)
Effective Date and Time of Initial Listing: April 9, 2014 12:01 AM ET
PSO Mailing Address: P.O. Box 750, Nashville, TN 37202
PSO Phone Number: (615) 344-2293
Point of Contact: Sharon Weidner Hickman
Point of Contact Phone: 615-344-1254
Point of Contact Email: Sharon.Hickman@hcahealthcare.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 04/09/2018 through 04/08/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
HPI Press Ganey PSO - P0185
Component of Parent Org(s):
  • Press Ganey
Effective Date and Time of Initial Listing: December 12, 2016 12:01 AM ET
PSO Mailing Address: 5041 Corporate Woods Drive Ste 180, Virginia Beach, VA 23462
PSO Phone Number: 913-800-4954
Point of Contact: Caryn Lea Woods
Point of Contact Phone: (757) 226-7479
Point of Contact Email: Caryn.Woods@pressganey.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 12/12/2018 through 12/11/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Health Catalyst Patient Safety Organization (HCPSO) - P0201
Component of Parent Org(s):
  • Health Catalyst, Inc
Effective Date and Time of Initial Listing: July 24, 2018 12:01 AM ET
PSO Mailing Address: 3165 E Millrock Dr. Suite 400, Salt Lake City, UT 84121
PSO Phone Number: (801) 708-6800
Point of Contact: Robert Michael Barton PharmD
Point of Contact Phone: 801-708-6800
Point of Contact Email: michael.barton@healthcatalyst.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 07/24/2020 through 07/23/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Institute for Safe Medication Practices (ISMP) - P0009
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
PSO Mailing Address: 200 Lakeside Drive, Suite 200, Horsham, PA 19044
PSO Phone Number: (215) 947-7797
Point of Contact: Ann D. Shastay RN, MSN, AOCN
Point of Contact Phone: (215) 947-7797
Point of Contact Email: ashastay@ismp.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2020 through 11/04/2022
Disclosures & Finding: None
Kentucky Institute for Patient Safety & Quality - P0022
Component of Parent Org(s):
  • Kentucky Hospital Association
Effective Date and Time of Initial Listing: November 26, 2008 12:01 AM ET
PSO Mailing Address: P.O. Box 436629, Louisville, KY 40253
PSO Phone Number: (502) 426-6220
Point of Contact: Nancy C. Galvagni
Point of Contact Phone: (502) 426-6220
Point of Contact Email: ngalvagni@kyha.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/26/2018 through 11/25/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Midwest Alliance for Patient Safety - P0087
Component of Parent Org(s):
  • Illinois Health and Hospital Association
Effective Date and Time of Initial Listing: April 28, 2010 12:01 AM ET
PSO Mailing Address: 1151 East Warrenville Road, Naperville, IL 60566
PSO Phone Number: 630-276-5682
Point of Contact: Carrie Pinasco
Point of Contact Phone: 630-276-5845
Point of Contact Email: cpinasco@team-iha.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 04/28/2020 through 04/27/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Nebraska Coalition for Patient Safety - P0076
Component of Parent Org(s):
  • Nebraska Academy of Physician Assistants
  • Nebraska Hospital Association
  • Nebraska Medical Association
  • Nebraska Nurses Association
  • Nebraska Pharmacists Association
  • Nebraska Pharmacists' Association
Effective Date and Time of Initial Listing: October 14, 2009 12:01 AM ET
PSO Mailing Address: 986055 Nebraska Medical Center, Omaha, NE 68198-6055
PSO Phone Number: 402-559-8421
Point of Contact: Gail E Brondum LPN
Point of Contact Phone: 402-559-8421
Point of Contact Email: gail.brondum@unmc.edu (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 10/14/2019 through 10/13/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Safety Culture Patient Safety Organization - P0175
Component of Parent Org(s):
  • Walmart Stores, Inc
Effective Date and Time of Initial Listing: December 14, 2015 12:01 AM ET
PSO Mailing Address: 702 SW 8th Street Mailstop 430, Bentonville, AR 72716
PSO Phone Number: 479-204-9188
Point of Contact: Susanne Hiland
Point of Contact Phone: 479-204-9188
Point of Contact Email: susanne.hiland@walmart.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 12/14/2019 through 12/13/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Strategic Radiology Patient Safety Organization LLC - P0144
Component of Parent Org(s):
  • Strategic Radiology LLC
Effective Date and Time of Initial Listing: June 19, 2013 12:01 AM ET
PSO Mailing Address: PO Box 1418, Palmetto, FL 34221
PSO Phone Number: (810) 210-9885
Point of Contact: Lisa A. Mead MS, CPHQ
Point of Contact Phone: (480) 794-0483
Point of Contact Email: lmead@strategicradiology.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 06/19/2019 through 06/18/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
TeamHealth Patient Safety Organization - P0067
Component of Parent Org(s):
  • TeamHealth, Inc.
Effective Date and Time of Initial Listing: July 1, 2009 12:01 AM ET
PSO Mailing Address: 265 Brookview Centre Way, Suite 400, Knoxville, TN 37919
PSO Phone Number: 865-293-5500
Point of Contact: Abbie Tapp-Pearson
Point of Contact Phone: 865-293-5382
Point of Contact Email: abbie_tapp-pearson@teamhealth.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 07/01/2019 through 06/30/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: Yes
True North Patient Safety Organization, Inc. - P0203
Component of Parent Org(s):
  • Northwell Health, Inc.
Effective Date and Time of Initial Listing: September 14, 2018 12:01 AM ET
PSO Mailing Address: 1985 Marcus Avenue Suite LL 106, Lake Success, NY 11042
PSO Phone Number: (516) 321-6363
Point of Contact: Mark P. Jarrett
Point of Contact Phone: (516) 321-6363
Point of Contact Email: MJarrett@truenorthpso.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 09/14/2018 through 09/13/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Vizient™ PSO - P0007
Component of Parent Org(s):
  • Vizient Inc
  • Vizient™ Data Services, LLC
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
PSO Mailing Address: 155 North Wacker Drive, 40th floor, Chicago, IL 60606
PSO Phone Number: 312-775-4100
Point of Contact: Ellen M. Flynn RN, MBA, JD
Point of Contact Phone: (312) 775-4292
Point of Contact Email: Ellen.Flynn@vizientinc.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2020 through 11/04/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No